Skip to content
Perrigo Company icon

Perrigo Company

PRGOStocksPharmaceuticals MajorUnited StatesNYSEUSD

Price

$15.37

Today

-0.5%

YTD

+10.7%

About

Perrigo Company PLC is a global healthcare company engaged in the manufacture and distribution of private label, over-the-counter pharmaceuticals for a worldwide audience, with around 70% of net sales coming from the U.S. healthcare system. The firm was founded in 1887 and is headquartered in Dublin, Ireland. The firm is focused on delivering a line of over-the-counter healthcare products, including infant formulas, oral self-care products, and generic pharmaceutical products. Perrigo is the firm behind brands such as Nytol, Niquitin, Bronchostop, Bio-Oil and Jungle Formula. The company is also engaged in the production of licensed formulations on behalf of other healthcare companies and retailers, as well as formulations under the firm’s own brand names, Galpharm and Perrigo. The firm sells its products primarily in North America and Europe, as well as in other markets, including Australia, Israel, and China. The firm’s brands are sold through merchandisers, supermarkets, drug stores, pharmacies, and e-commerce channels. The firm works in partnership with pharmacists, and offers training seminars, educational kits and CPD modules to support pharmacists in advising consumers regarding over-the-counter solutions. Perrigo is listed on the NYSE under the stock ticker PRGO. If you are interested in finding out more about PRGO stock add it to your eToro watchlist.

Price chart
Closing price history for PRGO (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-1.15
P/S (TTM)0.49
P/B (TTM)0.80
Market cap$2.00B
Cap tierMid-cap
Industry avg P/E-7.40

Profitability

Gross margin33.32%
EBIT margin6.42%
Net margin8.65%
ROE-48.75%
ROA-19.24%

Earnings & Revenue

Revenue (TTM)$4.14B
Revenue growth (1Y)-4.2%
EPS (TTM)-$12.51
Free cash flow$119.30M
Total debt$3.46B

Dividends & Risk

Dividend rate$1.16
Dividend yield8.03%
Ex-date29 May '26
Beta (5Y)0.74
Employees8,100
Next earnings4 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.